Results 71 to 80 of about 3,046,845 (266)
A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression
Molecular Oncology, EarlyView.Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak +8 more
wiley +1 more source
Conditional model order estimation [PDF]
IEEE Transactions on Signal Processing, 2001 zbMATH Open Web Interface contents unavailable due to conflicting licenses.
openaire +2 more sources
Molecular Oncology, EarlyView.Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece +18 more
wiley +1 more source
Abstract and Applied Analysis, 2013 We obtain a new Taylor's formula in terms of the order subdifferential of a function from to . As its applications in optimization problems, we build order sufficient optimality conditions of this kind of functions and order necessary conditions ...
He Qinghai, Zhang Binbin
doaj +1 more source
Molecular Oncology, EarlyView.A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
Molecular Oncology, EarlyView.Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
Molecular Oncology, EarlyView.HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto +13 more
wiley +1 more source
Explicit solutions for a system of first-order partial differential equations
Electronic Journal of Differential Equations, 2008 In this paper we construct explicit weak solutions of a system of two partial differential equations in the quarter plane ${(x,t):x>0,t>0}$ with initial conditions at $t=0$ and a weak form of Dirichlet boundary conditions at $x=0$. This system was
Kayyunnapara Thomas Joseph
doaj
First order systems of odes with nonlinear nonlocal boundary conditions
Electronic Journal of Qualitative Theory of Differential Equations, 2015 In this article, we prove existence of solutions for a nonlocal boundary value problem with nonlinearity in a nonlocal condition. Our method is based upon Mawhin's coincidence theory.
Igor Kossowski, Bogdan Przeradzki
doaj +1 more source
Molecular Oncology, EarlyView.Development of therapies targeting cancer‐associated fibroblasts (CAFs) necessitates preclinical model systems that faithfully represent CAF–tumor biology. We established an in vitro coculture system of patient‐derived pancreatic CAFs and tumor cell lines and demonstrated its recapitulation of primary CAF–tumor biology with single‐cell transcriptomics ...
Elysia Saputra +10 more
wiley +1 more source